Evidence for the association of the <it>SLC22A4 </it>and <it>SLC22A5 </it>genes with Type 1 Diabetes: a case control study
<p>Abstract</p> <p>Background</p> <p>Type 1 diabetes (T1D) is a chronic, autoimmune and multifactorial disease characterized by abnormal metabolism of carbohydrate and fat. Diminished carnitine plasma levels have been previously reported in T1D patients and carnitine in...
Main Authors: | Figueredo M Ángeles, Fernández-Arquero Miguel, de la Calle Hermenegildo, Martínez Alfonso, Santiago Jose, de la Concha Emilio G, Urcelay Elena |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-06-01
|
Series: | BMC Medical Genetics |
Online Access: | http://www.biomedcentral.com/1471-2350/7/54 |
Similar Items
-
Susceptibility to type 1 diabetes conferred by the <it>PTPN22 </it>C1858T polymorphism in the Spanish population
by: Figueredo M Ángeles, et al.
Published: (2007-08-01) -
Metformin Pharmacogenetics: Effects of SLC22A1, SLC22A2, and SLC22A3 Polymorphisms on Glycemic Control and HbA1c Levels
by: Laith N. AL-Eitan, et al.
Published: (2019-03-01) -
Interaction of Natural Dietary and Herbal Anionic Compounds and Flavonoids with Human Organic Anion Transporters 1 (SLC22A6), 3 (SLC22A8), and 4 (SLC22A11)
by: Li Wang, et al.
Published: (2013-01-01) -
Trospium Chloride Transport by Mouse Drug Carriers of the Slc22 and Slc47 Families
by: Matthias Gorecki, et al.
Published: (2021-12-01) -
Uptake Transporters of the SLC21, SLC22A, and SLC15A Families in Anticancer Therapy—Modulators of Cellular Entry or Pharmacokinetics?
by: Karin Brecht, et al.
Published: (2020-08-01)